Found: 12
Select item for more details and to access through your institution.
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐ascending‐dose study in healthy participants.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2634, doi. 10.1111/dom.15184
- By:
- Publication type:
- Article
Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2642, doi. 10.1111/dom.15150
- By:
- Publication type:
- Article
Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 4, p. 819, doi. 10.1007/s13300-024-01554-1
- By:
- Publication type:
- Article
Generating and Visualizing Spatially Disaggregated Synthetic Population Using a Web-Based Geospatial Service.
- Published in:
- Sustainability (2071-1050), 2021, v. 13, n. 3, p. 1587, doi. 10.3390/su13031587
- By:
- Publication type:
- Article
20-OR: GPR142 Agonists Increase Glucose-Dependent Insulin Secretion and Differentially Regulate Hormone Secretion in Preclinical and Phase 1 Studies.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-20-OR
- By:
- Publication type:
- Article
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 7, p. 1057, doi. 10.1007/s40262-022-01140-3
- By:
- Publication type:
- Article
The effect of age on insulin sensitivity and insulin secretion in first-degree relatives of type 1 diabetic patients: a population analysis.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Imaging spectral device based on multiple volume holographic gratings.
- Published in:
- Optical Engineering, 2004, v. 43, n. 9, p. 2009, doi. 10.1117/1.1775231
- By:
- Publication type:
- Article
Development and Verification of a Body Weight–Directed Disease Trial Model for Glucose Homeostasis.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 2, p. 234, doi. 10.1002/jcph.1728
- By:
- Publication type:
- Article
Pharmacodynamics of Metformin in Pregnant Women With Gestational Diabetes Mellitus and Nonpregnant Women With Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 4, p. 540, doi. 10.1002/jcph.1549
- By:
- Publication type:
- Article
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 21, p. 2075, doi. 10.1001/jama.2023.21835
- By:
- Publication type:
- Article
Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 6, p. 1362, doi. 10.1002/cpt.1749
- By:
- Publication type:
- Article